We were able to define highly significant protein profiles as biomarkers that separated MG from HCs and that also separated subgroups, which could indicate important differences reflecting MG immunopathogenesis.
← all excerpts
Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.
1
—
—